EMAIL THIS PAGE TO A FRIEND

Journal of immunology (Baltimore, Md. : 1950)

Inhibition of System Xc(-) Transporter Attenuates Autoimmune Inflammatory Demyelination.


PMID 26071560

Abstract

T cell infiltration into the CNS is a significant underlying pathogenesis in autoimmune inflammatory demyelinating diseases. Several lines of evidence suggest that glutamate dysregulation in the CNS is an important consequence of immune cell infiltration in neuroinflammatory demyelinating diseases; yet, the causal link between inflammation and glutamate dysregulation is not well understood. A major source of glutamate release during oxidative stress is the system Xc(-) transporter; however, this mechanism has not been tested in animal models of autoimmune inflammatory demyelination. We find that pharmacological and genetic inhibition of system Xc(-) attenuates chronic and relapsing-remitting experimental autoimmune encephalomyelitis (EAE). Remarkably, pharmacological blockade of system Xc(-) 7 d after induction of EAE attenuated T cell infiltration into the CNS, but not T cell activation in the periphery. Mice harboring a Slc7a11 (xCT) mutation that inactivated system Xc(-) were resistant to EAE, corroborating a central role for system Xc(-) in mediating immune cell infiltration. We next examined the role of the system Xc(-) transporter in the CNS after immune cell infiltration. Pharmacological inhibitors of the system Xc(-) transporter administered during the first relapse in a SJL animal model of relapsing-remitting EAE abrogated clinical disease, inflammation, and myelin loss. Primary coculture studies demonstrate that myelin-specific CD4(+) Th1 cells provoke microglia to release glutamate via the system Xc(-) transporter, causing excitotoxic death to mature myelin-producing oligodendrocytes. Taken together, these studies support a novel role for the system Xc(-) transporter in mediating T cell infiltration into the CNS as well as promoting myelin destruction after immune cell infiltration in EAE.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB2500462
Anti-GFAP antibody produced in goat, affinity isolated antibody, buffered aqueous solution
C106
CGS-12066 maleate salt, solid
C17H17F3N4 · C4H4O4
SRP4038 Fgf-2 from mouse, recombinant, expressed in E. coli, ≥95% (SDS-PAGE), ≥95% (HPLC)
SRP4039 Fgf-2 from rat, recombinant, expressed in E. coli, ≥97% (SDS-PAGE), ≥97% (HPLC)
SRP4037 FGF-2 human, recombinant, expressed in E. coli, ≥95% (SDS-PAGE), ≥95% (HPLC)
SRP2092
FGF-2 human, recombinant, expressed in insect cells, ≥85% (SDS-PAGE)
P9333
Potassium chloride, BioXtra, ≥99.0%
ClK
P9541
Potassium chloride, for molecular biology, ≥99.0%
ClK
P5405
Potassium chloride, powder, BioReagent, suitable for cell culture, suitable for insect cell culture, ≥99.0%
ClK
P1597
Potassium chloride, meets EP, USP testing specifications
ClK
449989
Potassium chloride, anhydrous, beads, −10 mesh, 99.999% trace metals basis
ClK
451029
Potassium chloride, anhydrous, beads, −10 mesh, 99.99% trace metals basis
ClK
409316
Potassium chloride, 99.999% trace metals basis
ClK
204099
Potassium chloride, ≥99.99% trace metals basis
ClK
60128
Potassium chloride, BioUltra, for molecular biology, ≥99.5% (AT)
ClK
P9327
Potassium chloride solution, 0.075 M, sterile-filtered, BioXtra, suitable for cell culture
ClK
60142
Potassium chloride solution, BioUltra, for molecular biology, ~1 M in H2O
ClK
44675
Potassium chloride solution, 1 M
ClK
P5629
Potassium phosphate tribasic, reagent grade, ≥98%
K3O4P
107360
Pyruvic acid, 98%
C3H4O3
W297003
Pyruvic acid, ≥97%, FG
C3H4O3
W297070
Pyruvic acid, natural, ≥80%
C3H4O3
P76209
Pyruvic acid, 95%
C3H4O3
342483
Sodium phosphate, 96%
Na3O4P
S9133
Sodium selenite, γ-irradiated, lyophilized powder, BioXtra, suitable for cell culture
Na2O3Se
S5261
Sodium selenite, BioReagent, suitable for cell culture, ≥98%
Na2O3Se
214485
Sodium selenite, 99%
Na2O3Se